USA – Phantom Neuro, a Texas-based neurotechnology company, has raised US$ 19 million in an oversubscribed Series A funding round, pushing its total funding to US$ 28 million.
The company, which is developing technology to make robotic prosthetics feel like natural extensions of the human body, plans to use the fresh capital to enter human trials and expand its research efforts.
The round was led by Ottobock, a global leader in prosthetic and mobility solutions. Existing investors like Draper Associates, Time BioVentures, and Breakout Ventures also participated.
Other new backers included METIS Innovative, e1 Ventures, Actual VC, MainSheet Ventures, Jumpspace, and Brown Advisory.
What Phantom Neuro does
Phantom Neuro was spun out of the Johns Hopkins University School of Medicine and focuses on bridging the gap between human intent and robotic movement.
Its flagship technology, Phantom X, is a peripheral neural interface that allows people to control advanced prosthetics or robotic exoskeletons using muscle signals.
Unlike older-generation prosthetic devices that require manual switches or basic signals, Phantom X enables more natural and fluid control—making artificial limbs behave more like real ones.
The technology taps into the user’s nervous system to interpret movement intentions in real-time.
“Ottobock’s investment shows the growing alignment between prosthetics, robotics, and neurotechnology,” said Dr. Connor Glass, founder and CEO of Phantom Neuro.
“Together, we’re working toward a future where assistive devices are so advanced, they feel like part of the body.”
What’s next?
The Series A funds will help Phantom Neuro move closer to real-world use. The company plans to:
Phantom X already received two important designations from the U.S. FDA in March 2025: Breakthrough Device and Targeted Acceleration Pathway (TAP).
These programs are meant to speed up the review process for technologies that address unmet medical needs.
The bigger picture
This isn’t Phantom Neuro’s first leap forward. In 2023, the company teamed up with Silicon Labs Wi-Fi to add edge computing to its implantable systems.
This means its devices can process data directly on the prosthetic or implant, reducing the need for constant cloud connectivity.
Earlier, in 2022, Phantom Neuro joined forces with Blackrock Neurotech, a brain-computer interface pioneer, to fast-track the development of Phantom X.
The ultimate goal? To create prosthetics and assistive devices that respond as smoothly and intuitively as natural limbs—combining AI, surgery, robotics, and neuroscience in one revolutionary system.
XRP HEALTHCARE L.L.C | License Number: 2312867.01 | Dubai | © Copyright 2025 | All Rights Reserved